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Abstract 24 
Background: After neonatal asphyxia, therapeutic hypothermia (HT) is the only proven treatment 25 
option. Although established as a neuroprotective therapy, benefit from HT has been questioned 26 
when infection is a comorbidity to hypoxia-ischaemic (HI) brain injury. Gram-negative and gram-27 
positive species activate the immune system through different pathogen recognition receptors and 28 
subsequent immunological systems. In rodent models, gram-negative (lipopolysaccharide, LPS) 29 
and gram-positive (PAM3CSK4 (PAM)) inflammation similarly increase neuronal vulnerability to 30 
HI. Interestingly, while LPS pre-sensitisation negates HT neuroprotective effect, HT is highly 31 
beneficial after PAM-sensitised HI brain injury.  32 
Objective: We aimed to examine whether systemic gram-positive or gram-negative 33 
inflammatory sensitisation, affects juvenile rat pups per se, without an HI insult.  34 
Methods: Neonatal P7 rats (n=209) received intraperitoneal injections of vehicle (0.9%NaCl), 35 
LPS (0.1mg/kg) or PAM (1 mg/kg). Core temperature and weight gain was monitored. Brain 36 
cytokine expression (IL-6, IL-1β, TNF-α, IL-10) (PCR), apoptosis (cCas3 3) (western blots), and 37 
microglial activation (Iba-1) (immunohistochemistry) was examined.  38 
Results: LPS induced an immediate drop in core temperature followed by poor weight gain, not 39 
seen after PAM. Furthermore, LPS induced brain apoptosis, while PAM did not. The magnitude 40 
and temporal profile of brain cytokine expression was differed between LPS- and PAM-injected 41 
animals.  42 
Conclusion: These findings reveal sepsis-like conditions and neuro-inflammation specific to the 43 
inflammatory stimulus (gram-positive versus gram-negative), in the neonatal rat. They emphasize 44 
the importance of pre-clinical models being carefully tailored to their clinical scenario.  45 
 46 
 47 
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Background  48 
 49 
In industrialised countries, early onset sepsis (EOS) have an incidence of 0.5-1.2 per 1000 live-50 
borns [1]. Systemic inflammation increases the vulnerability of the neonatal brain to hypoxic-51 
ischaemic (HI) insults, and is considered a risk factor for neurodevelopmental sequelae [2]. 52 
Although therapeutic hypothermia (HT) is an effective neuroprotective strategy after HI injury, 40-53 
50% of patients still have poor developmental outcome including death [3]. As clinical trials of HT 54 
in parts of the world where infection rates are higher failed to show benefit, clinicians and 55 
researchers are questioning whether comorbidities such as perinatal infection could negate the 56 
neuroprotective effect of HT [2,4]. Exposure of the 7-day-old (P7) rat to LPS prior to a mild HI 57 
insult significantly increased brain injury and abolished the neuroprotective effects of HT [5], 58 
supporting that hypothesis. However, LPS only represent gram-negative type bacterial infections. 59 
Gram-negative and gram-positive species activate the immune system through different pathogen 60 
recognition receptors and subsequent immunological pathways [6]. While LPS binds primarily to 61 
toll-like receptor (TLR)-4, gram-positive bacterial cell wall molecules adheres to TLR-2 on the 62 
host immune cells, to activate the inflammatory cascade, and have been shown to be TLR-4 63 
independent (Fig.1) [6]. Pre-sensitising with the synthetic TLR-2 agonist, PAM3CSK4 (PAM), in 64 
the same neonatal rat model of HI brain injury, simulated gram-positive type infection and induced 65 
brain injury of the same severity, but the neuroprotective effect of HT was preserved [7].  66 
Although in most cases of EOS the causative agent remains unidentified, a recent population-based 67 
study showed that 91% of culture-positive sepsis cases among term-born babies were caused by 68 
gram-positive bacterial species [8].  69 
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 70 
 71 
Figure 1. Inflammatory activation by gram-positive and gram-negative bacteria 72 
Recognition of gram-negative (LPS) and gram-positive (LTA, PG, PAM3CSK4) bacterial 73 
pathogen associated molecular patterns (PAMPs) by plasma membrane-localized TLR-4 and 74 
TLR-2 (TLR-2 forms a heterodimer with TLR-1 or TLR-6 to form a functional receptor 75 
complex).  TLR-2 and TLR-4 both act through the MyD88-dependent signalling pathway, where 76 
the active IкB kinase (IKK) complex activates nuclear factor kappa B (NF-κB) subunits to 77 
initiate the transcription of inflammatory cytokines. TLR-4 also activates MyD88-independent 78 
signalling by recruiting TIR-domain-containing adaptor-inducing interferon-β (TRIF). Here 79 
activation of the TANK-binding kinase 1 (TBK1)/IKK inhibitor (IKKi) complex results in the 80 
production of inflammatory cytokines and type I interferons (modified from Kumar et al. [33]). 81 
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Using neonatal rat pups without inducing HI brain injury, we investigated differences in 82 
inflammatory response to triggers of TLR-2 and TLR-4 respectively, with focus on temporal core 83 
temperature changes, development of intracerebral apoptotic cell death and neuro-inflammatory 84 
markers, and weight gain representing well-being in the neonate. 85 
 86 
Material and Methods 87 
Animals and injections 88 
All experiments were approved by the University of Oslo's Animal Ethics Research 89 
Committee. Experiments were performed on P7 Wistar rats (Charles River Laboratories, 90 
Sulzfeld, Germany) of both genders. All pups were kept in an animal facility with a 12:12-h 91 
dark:light cycle at 21°C environmental temperature with food and water ad libitum. Animals 92 
were always randomised across litter, sex and weight before the experiments commenced.  93 
We used LPS from Escherichia coli 055:B5 (Sigma) (0.1mg/kg), and the synthetically 94 
manufactured TLR-2/1 agonist PAM3CSK4 (Vaccigrade, Sigma-Aldrich) (1mg/kg). Vehicle 95 
(Veh) for dilutions was sterile 0.9% NaCl. The LPS dose is one that previously sensitised the 96 
neonatal brain to HI brain injury [5]. We based the PAM dose on previous publications [9], as 97 
well as our own dose-response experiments from developing the model of PAM-sensitised HI brain 98 
injury [7]. The PAM model was developed to explore neuroprotective effect of hypothermia after 99 
PAM-sensitised HI brain injury. We therefore aimed for a dose which induced the same level of 100 
infection-sensitised injury as in our LPS-sensitised model, where hypothermic neuroprotection was 101 
negated [5]. Control groups received a single dose of Veh. All injections were given 102 
intraperitoneally (i.p.) in a volume of 10µl/g body weight, at room temperature (21°C).  103 
 104 
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Core temperature recordings  105 
P7 rats (n=29) received a Veh (n=9), LPS (n=10), or PAM (n=10) injection. Core temperature 106 
was monitored using a rectal probe (IT-21, Physitemp Instruments, Clifton, NJ, USA) at 9 selected 107 
time points after injection (0, 1, 2, 4, 6, 8, 10, 12, and 24h). All groups were handled similarly 108 
throughout the experiment, performed in a temperature-controlled room (21±0.5°C). To record the 109 
individual nesting temperature at a given time, one pup was removed from the dam at a time for 110 
temperature recording before returnal to the dam.  111 
 112 
Weight gain analysis 113 
In a separate study, P7 pups (n=36) received injections as described, and returned to their dams. At 114 
P14 all pups were weighed separately. Weight gain was calculated as percentage gain from P7 - 115 
P14.  116 
 117 
Brain apoptosis 118 
The apoptotic protein marker, cleaved caspase 3 (cCas3), was examined in brain tissue at 24 and 119 
48h survival post injections using western blot (WB) technique as previously described [10]. Three 120 
groups were examined at 24h (n=36); Veh, LPS and PAM. For the 48h follow-up only LPS and 121 
PAM data were available (n=6 per group). Image Lab (Image Lab Software, version 5.2.1; BioRad, 122 
Calif., USA) was used for optical density measurements of protein signals on scans in ChemiDocTM 123 
Touch Imaging Systems (BioRad).  124 
 125 
 126 
Brain Cytokine expression 127 
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Using qRT-PCR, we studied the time course of pro- (IL-6, IL-1ß, TNF-α) and anti-inflammatory 128 
(IL-10) cytokines expressed in brain tissue after systemic LPS-injection (n=50), over a 48h period. 129 
Subsequently, the same cytokines were examined in brain tissue after systemic injections of PAM 130 
(n=50), or Veh (n=50). Nine post-injection time points were selected for analysis in LPS- and 131 
PAM-injected animals (0, 2, 4, 6, 12, 18, 24, 36 and 48h). Four time points (0, 4, 8 and 24h) were 132 
selected in the Veh group (Fig. 4). Brains were harvested at the selected time points, and snap 133 
frozen in liquid nitrogen before storage at -80°C. 134 
Using RNeasy mini kit (Qiagen), total RNA was extracted, and concentration measured with 135 
NanoDrop spectrophotometer. cDNA was synthesised from 1µg RNA using the qScriptTM cDNA 136 
Synthesis Kit (Quanta Biosciences). qRT-PCR was performed with the ABI7900 sequence 137 
detection system (PE applied biosystems, Foster City, CA, USA) in a 10µl total volume, using 138 
commercial TaqMan® Gene Expression Assays (Applied Biosystems) and the Universal TaqMan 139 
Master Mix (PE Applied Biosystems, CAS # 67-68-5). PCR cycling conditions were: 2min at 50°C 140 
and 10min at 95°C, before 40 x (15 seconds at 95°C and 1min at 60°C). Using relative 141 
quantification method, all values were normalized to the housekeeping gene, GAPDH, in the same 142 
sample. The inflammatory response in terms of expression of these cytokines was plotted against 143 
time, and expressed relative to their level at time point zero.  144 
 145 
Microglial activation 146 
Ionized calcium binding adaptor molecule 1 (Iba1) was examined by WB technique at 48h post 147 
injections as described previously (n=18) [10]. 148 
Iba1 immunoreactivity was analysed in animals with 7 days’ survival (n=30), as described 149 
previously [10]. Virtual slides were exported as high-resolution tiff images for further analysis with 150 
ImageJ software (ImageJ, version 1.46r, National Institutes of Health, Bethesda, MD), detecting 151 
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Iba1 immunoreactivity. The summed intensity detected was analysed by two individual observers 152 
blinded to the treatment groups. Inter-rater reliability was crosschecked using Pearson correlation 153 
coefficient analysis. An average of the two was taken for comparison across treatment groups. 154 
Microglial activation was expressed as Iba1 detected relative to hemispheric area in the same brain. 155 
 156 
Statistical Data analyses 157 
Statistical analyses were performed using GraphPad Prism version 6 (GraphPad Software Inc., La 158 
Jolla, Ca, USA). Temperature measurements are presented as mean ±SEM. For weight gain as well 159 
as cytokine and WB analysis, descriptive data are presented as median with 95% confidence 160 
intervals (CI) as these data were not normally distributed. Multi-group comparisons were done 161 
using Kruskal-Wallis test, and Mann-Whitney-Wilcoxon rank sum tests for comparing two groups 162 
to get exact two-tailed p-values. Due to the variable spread in cytokine expression data, 163 
Kolmogorov-Smirnov test was used for group-to-group comparisons. A p-value <0.05 (two-sided) 164 
was considered statistically significant. 165 
 166 
Results 167 
Core temperature changes 168 
Already 2h after injection of LPS, mean core temperatures had dropped by 4.3°C (2.7-6.4), a 169 
significantly greater temperature reduction than in Veh- and PAM-injected animals, which dropped 170 
by 2.5°C (0.2-3.0)(p< 0.01) and 2.1°C (1.1-4.8)(p<0.01), respectively. It took 8h before core 171 
temperatures in the LPS-injected group increased to the same value as PAM and Veh (Fig. 2). 172 
 173 
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 174 
Figure 2. Core temperature developments after systemic injections 175 
Sequential core temperature measurements (°C) of P7 rat pups over 24 h following i.p. injections 176 
of Veh (n=9), LPS (n=10), or PAM (n=10) expressed as mean ± SEM. ** p < 0.01. 177 
 178 
 179 
Differences in weight gain 180 
The Veh- and PAM-groups had similar median weight gain one week after injections, 138% 181 
(130.5-145.5) and 145.6% (134.1-137.1) respectively. The LPS-injected pups, however, had 182 
significantly poorer weight gain at median 115.2% (91.5-138.9) compared to the Veh-group 183 
(p=0.02) and the PAM-group (p<0.01). 184 
 185 
Intracerebral apoptosis  186 
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cCas3 was significantly increased in the brains of LPS-injected animals after 24h, compared to the 187 
Veh (p<0.0001) and the PAM groups (p<0.0001). cCas3 continued to increase the next 24h in LPS 188 
animals. After PAM there was no elevation of cCas3 at 24 h post-injection, similar to after injection 189 
of Veh, nor did it elevate over the next day (Fig.3B).  190 
 191 
 192 
Figure 3. Apoptotic activation in brain after systemic injections (WB) 193 
The Western blot with ladder on top (A), loaded with Veh (1), LPS (2), PAM (3) in repeated 194 
sequences. The first band is the un-cleaved caspase 3 protein at 36 kDa. Below are the cleaved 195 
subunits after activation with bands at 19 and 17 kDa. B: Box-&-Whiskers plot of cCas3 196 
expression in brain tissue at 24 and 48 h after injections.  *** p < 0.001. 197 
 198 
Cytokine expression in brain tissue 199 
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The temporal changes in cerebral cytokine expression (IL-6, IL-1β, TNF-α, IL-10) after peripheral 200 
injections of PAM and LPS are shown in table 1. After injection of Veh, none of the four cytokines 201 
were significantly elevated at any time (Fig. 4A).  202 
Up-regulation of cerebral cytokines was found to be specific to the stimulus (Fig. 4B). After LPS, 203 
IL-6 expression increased rapidly within 2h, and after a second peak at 12h returned to baseline 204 
levels. After PAM-injection there was a later (6h) significant change in the IL-6 level. Expression 205 
of TNF-α was also significantly increased already 2h after LPS injection. The TNF-α peak induced 206 
by PAM-injection was seen later, at 6-12h. IL-1β expression was strongly up-regulated in both 207 
groups, but while also this pro-inflammatory cytokine immediately rose in the LPS-group, the 208 
response was somewhat delayed in the PAM-group.  209 
The pattern was different for IL-10. A small but significant change was seen 6h after LPS-injection, 210 
while in PAM-animals the IL-10 response was immediate and sustained.  211 
  212 
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 IL-6 IL-1β TNF-α IL-10 
LPS 0.001* (KW)  0.049* (KW) 0.002* (KW) 0. 135 (KW) 
2 h 0.008* 0.008* 0.008* 0.05 
4 h 0.338   0.015* 0.03* 0.242 
6 h 0.084  0.015* 0.03* 0.026* 
12 h 0.026* 0.015* 0.015* 0.061 
18 h 0.264 0.286 0.079 0.286 
24 h 0.873 0.048 0.079 0.05 
36 h 0.079 0.008* 0.714 0.167 
48 h 0.286 0.008* 0.079 0.079 
PAM  <0.001* (KW)  0.001* (KW) 0.002* (KW)   0.05 (KW) 
2 h 0.286 0.061  0.357 0.008* 
4 h 0.896 0.026* 0.069 0.069 
6 h  0.026* 0.008* 0.004* 0.004* 
12 h 0.08 0.004* 0.008* 0.008* 
18 h 0.286 0.016* 0.1 0.048* 
24 h 0.351 0.286 0.108 0.108 
36 h 0.81 0.143 0.008* 0.357 
48 h 0.873 0.357 0.079 0.047 
 213 
Table 1. Changes in cerebral cytokine expression (p-values) after systemic injections of 214 
PAM or LPS (hours, h).  215 
Kruskal-Wallis test (KW) for multi-group comparisons. Changes in expression of each specific 216 
cytokine was compared against the same cytokine at 0 h (n=5), using Kolmogorov-Smirnov test.  217 
* significant, p<0.05. 218 
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 219 
 220 
Figure 4. Cytokine expressions in brain tissue (PCR) 221 
Y-axis values are cytokine expression relative to expression of a house keeping protein (GAPDH) 222 
in the same tissue sample (arbitrary units). The lines are drawn through the median for each time 223 
point, with error bars showing 95% CI. A: Temporal expression of IL-6, TNF-α, IL-10 and IL-1β 224 
after i.p. injection of Veh (n=7-14 per time point). B: Graphs show temporal profiles of specific 225 
cytokines (IL-6, TNF-α, IL-10 or IL-1β) after a single i.p. PAM- (triangles, complete line) or LPS-  226 
(circles, dotted line) injection (n=5-6).  227 
 228 
 229 
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Microglial activation in response to systemic injections 230 
Western blots from snap frozen brain tissue collected 48h post injections showed no differences 231 
between LPS- (1.5; 1.2-1.9) and PAM animals (1.4; 1.3-1.6). Iba1 was however significantly higher 232 
in animals which had received LPS or PAM compared to Veh (1.2; 1.0-1.4) (p=0.04 for both 233 
comparisons)(Fig. 5A). 234 
Immunofluorescence-labelled Iba1-specific antibodies revealed microglia throughout the brains of 235 
pups from all groups at P14. Again there was no difference between LPS- (87.8; 40.4-136) and 236 
PAM-injected (71.5; 56.4-108.3) animals. Median Iba1-labelling detected was higher in pups 237 
which had received LPS or PAM, than in Veh animals (33.1; 24.6-138.6), although not statistically 238 
significant (p=0.21 and p=0.28). By appearance there was no obvious difference in number of 239 
microglia across the three groups, however microglia in the activated state were found in LPS- and 240 
PAM-injected animals, as opposed to in the Veh group (Fig. 5B-D).  241 
 242 
 243 
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 244 
 245 
Figure 5. Iba1 expressions after systemic injections (IHC) 246 
A: Box-&-Whiskers plot of Iba1 expression in brain tissue 48h after injections (WB). *p <.05. 247 
Representative IHC images from the Veh-group (B), the LPS-group (C) and the PAM-group (D). 248 
Iba1 expression is seen as green. DAPI (blue) stains nuclei. Magnified in picture A is a typical 249 
ramified resting microglia. Picture B and C show microglia in the activated state, with larger 250 
rounded somata and withdrawn dendritic processes.  251 
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Discussion 252 
In this study of juvenile rats with brain maturation equal to near-term humans, we found 253 
pathogen dependent inflammatory responses after either LPS (a gram-negative type stimulus) or 254 
PAM (a gram-positive stimulus) administration.  255 
When term new-born infants need HT after perinatal asphyxia, cooling starts within a few hours. 256 
It is a major question whether infection negates the neuroprotective effect of HT. To a similar 257 
degree, pre-sensitisation with LPS and PAM increased injury at normothermic recovery [7,11]. 258 
With experimental HI followed by HT, LPS negated neuroprotection [5], unlike PAM, where HT 259 
had significant effect [7]. With current diagnostic methods, the causative pathogen in case of a 260 
concomitant infection cannot be revealed in time to impact the decision of whether to cool or not. 261 
However, if most infections in term born neonates in the industrialised part of the world are caused 262 
by gram-positive pathogens [8,12], the decision to cool should not be delayed by these diagnostic 263 
challenges.  264 
To further explore differences between two clinically relevant immune response pathways, the 265 
current study addresses the effect of LPS and PAM on physiology and neuropathology in juvenile 266 
animals without an HI injury.   267 
 268 
Within 2h after LPS administration core temperature dropped significantly in these P7 rat pups, 269 
unlike in the Veh- or PAM-injected animals. With the exception of a brief temperature reduction 270 
following injection of a room-tempered solution (21°C), the temperature development of Veh- or 271 
PAM animals remained steady. Rodents have previously been shown to develop hypothermia in 272 
response to a significant systemic infection [13]. However, in most studies on rodent sepsis the 273 
stimulants have been gram-negative bacteria or LPS injection. In human sepsis, loss of core 274 
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temperature (“cold sepsis”) is thought to indicate a more severe generalised disease state with 275 
higher mortality [14]. When spontaneous drop in core temperature is a result of HI brain injury, it 276 
has been shown to be a strong predictor of poor outcome [15]. It is reasonable to interpret the 277 
temperature changes seen after LPS here as a sign of a more severe generalised disease state, than 278 
what is seen in littermates who received PAM.  279 
 280 
Microglial activation was seen both at 48h and at 7 days after PAM and LPS injections, and to a 281 
similar degree. This supports the idea that inflammatory activation in blood leads to activation of 282 
the monocyte line in the CNS [16]. Some, or even a majority, of the Iba1 positive cells seen in the 283 
brain after systemic inflammation are peripheral monocytes [17]. TNF-α was shown to play a major 284 
role in recruitment of these cells from blood to brain [18]. IL-6 is a key factor stimulating microglial 285 
activation and proliferation [19]. Both LPS and PAM induced significant elevations of TNF-α and 286 
IL-6 well within the time point where we analysed microglial activation, and can therefore explain 287 
the similarity of Iba1 density.  288 
The activation of monocytes/microglia and their release of pro-inflammatory molecules induce 289 
cellular death [20]. Kim et al. attributed LPS-induced neurotoxicity and apoptosis to microglial 290 
density [20]. Interestingly however, apoptosis was induced in LPS-injected animals, but not in the 291 
PAM-injected ones (Fig.3). This suggests that the mechanism of inflammatory induced apoptosis 292 
is not restricted simply to microglial/monocytal activation, but might be modified by microglial 293 
phenotype or other immunological events, especially in gram-positive type inflammation. 294 
 295 
The LPS-induced apoptosis demonstrated above is in line with previous studies [21]. The authors 296 
concluded that the LPS-induced changes could be interpreted as downstream effects of sepsis. The 297 
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profound differences between these two main pathways of inflammatory activation has clinical 298 
importance in the context of injurious impact of systemic infection on the immature brain; in 299 
sensitisation of the term neonatal brain to HI injury, as well as in white matter injury induced by 300 
systemic inflammation in the premature [22]. Our findings suggest that the mechanisms behind 301 
these phenomena are complex and not only the inflammation per se. The differing temporal 302 
patterns of various pro- and anti-inflammatory cytokines might play an important role.  303 
 304 
IL-6 and TNF-α play important roles in thermal response to inflammation [23], and increased 305 
sickness behaviour [24]. Our findings of intracerebral IL-6 and TNF-α surges already 2h after LPS-306 
injection, which coincide with a drop in core temperature, supports the thermoregulatory role of 307 
these cytokines, and explains a reduction in food intake. The increased IL-6 and TNF-α level in the 308 
brains of PAM-injected pups only reach statistical significance after a 6-12 h delay. Here, however, 309 
they peak without a concomitant change in core temperature, and with satisfactory weight gain. As 310 
opposed to in LPS animals, the increased IL-6 and TNF-α in PAM animals was accompanied by 311 
an elevated IL-10 level.  312 
IL-1β expression was significantly increased after both LPS and PAM injections. IL-10 was briefly 313 
elevated after LPS, while significantly increased at 2h and maintained elevated until 18h, after 314 
PAM. Several studies suggest a protective role of IL-10 through modulation of on-going 315 
inflammation. IL-10 reduced excitotoxic brain injury triggered by IL-1β in neonatal mice [25]. A 316 
genetic polymorphism that results in increased production of IL-10 has been associated with 317 
decreased white matter injury and reduced risk of CP in studies on very premature infants [26], 318 
also supporting the neuroprotective role of IL-10.  319 
 320 
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Due to the limitation of crushed tissue, we have not studied the intracerebral responses regionally. 321 
Specifically, LPS induced apoptosis in cultured neurons and microglia, but not in astrocytes [27], 322 
and apoptosis have been shown to be dependent on cell type density for various brain regions [20]. 323 
Exploring regions known to be particularly vulnerable to HI like the hippocampus and cortex could 324 
also help elucidate inflammatory sensitisation and its relation to temperature changes. Another 325 
significant limitation to this study is the challenge of interpretation. Current knowledge on specific 326 
cytokines and their action in pathologic situations are uncertain. Additionally, studies on translation 327 
of immune responses from rodents to humans are scarce [28].  328 
 329 
Researchers have approached a sepsis-like scenario by using LPS in various animal models 330 
spanning a wide range of clinical fields [29,30]. LPS is relatively inexpensive, and thoroughly 331 
investigated as a potent inflammatory trigger. However, the limitation that LPS exclusively 332 
represents gram-negative infections has not often been addressed. Our findings raise the question 333 
of how other inflammatory triggers, both acute and chronic, including viral and parasitic infections, 334 
may affect outcome after HI. Both hypoxia and LPS prior to the HI insult have displayed pre-335 
conditioning activities, and the timing is determinant for the outcome [31,32]. The physiological 336 
and neuroinflammatory responses in various settings of inflammation are under constant 337 
investigation. How they as co-morbidities to HIE might modify hypothermic neuroprotection is 338 
still unknown.  339 
We can conclude that the temporal upregulation of these mediators of cellular death and 340 
inflammation are different for analogues of a gram-positive and gram-negative systemic infection, 341 
with different downstream thermoregulatory effects, in the neonatal rat. Therefore, it is important 342 
to acknowledge that using LPS in pre-clinical models of inflammation may not always reflect the 343 
clinical scenario appropriately.  344 
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